Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

NCT01707264 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Prothena Biosciences Ltd.